Isolagen, an aesthetic and therapeutic company, has announced positive top-line efficacy results from a Phase II/III clinical study of the Isolagen Therapy for the treatment of moderate to
MiddleBrook Pharmaceuticals, a developer and marketer of anti-infective products, has reported net loss of $11.6m for the fourth quarter of 2008, compared to a net loss of $9.1m
Initiate Systems, a provider of master data management solutions, has announced that UMass Memorial Health Care of Worcester, Massachusetts, has selected its Initiate Interoperable Health software to provide
Power Medical Interventions, a manufacturer and marketer of intelligent surgical instruments, has reported a net loss applicable to common shares of $9.4m, or $0.55 per basic and diluted
China Sky One Medical has obtained production approval from the State Food and Drug Administration in China for calcium folinate injection. The company said that another two new
Xoft, a radiation oncology company, has received clearance from the FDA for a skin and surface treatment applicator for use with the Axxent electronic brachytherapy system to deliver
Pharmexa, a biotechnology company, and Affitech AS, a human therapeutic antibody discovery and engineering company, have entered into a conditional agreement to merge the two companies by means
UK-based Stem Cell Sciences has entered into a definitive agreement with StemCells, a US-based biotechnology company, for the sale of the trading subsidiaries of the company and certain
In accordance with Marketplace Rule 4310(c)(8)(C), the company has been provided a period of 90 calendar days, through June 4, 2009, to regain compliance with the Rule. The
Access Pharmaceuticals, a biopharmaceutical company, has announced positive safety and efficacy results from its Phase II monotherapy clinical study of ProLindac in late-stage, heavily pretreated ovarian cancer patients.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.